Abel Hall LLC
PFE icon

Abel Hall LLC’s Pfizer PFE Stock Holding History

Abel Hall LLC’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.23M Buy
43,247
+2,626
+6% +$69.8K 0.22% 56
2026
Q2 		$978K Sell
40,621
-3,091
-7% -$80.9K 0.17% 86
2026
Q1 		$1.23M Buy
43,712
+15,988
+58% +$426K 0.26% 55
2025
Q4 		$690K Buy
27,724
+1,382
+5% +$34.9K 0.16% 103
2025
Q3 		$671K Buy
26,342
+442
+2% +$10.9K 0.27% 53
2025
Q2 		$628K Buy
25,900
+14,395
+125% +$336K 0.29% 58
2025
Q1 		$292K Buy
11,505
+3,378
+42% +$88.4K 0.18% 105
2024
Q4 		$216K Sell
8,127
-4,377
-35% -$119K 0.14% 121
2024
Q3 		$362K Buy
12,504
+62
+0.5% +$1.81K 0.24% 70
2024
Q2 		$348K Sell
12,442
-354
-3% -$9.7K 0.25% 73
2024
Q1 		$355K Buy
12,796
+1,456
+13% +$40.4K 0.27% 64
2023
Q4 		$326K Buy
+11,340
New +$343K 0.28% 64

Other funds holding PFE

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $40B AUM 30.45% 1-Year Est. Return
Fort Washington Investment Advisors
Fort Washington Investment Advisors Cincinnati, Ohio $19.7B AUM 20.11% 1-Year Est. Return

Abel Hall LLC's PFE Position: Q3 2026 in Review

Abel Hall LLC increased its Pfizer (PFE) stake by 6.5% in Q3 2026, buying an estimated $69.8K and bringing the position to 43,247 shares worth $1.23M. The position accounts for 0.22% of the portfolio, ranked #56.

Abel Hall LLC first reported a position in PFE in Q4 2023 and has held it in 12 quarters since. 1,037 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Abel Hall LLC held 43,247 shares of Pfizer worth $1.23M as of Q3 2026.
  • Abel Hall LLC bought 2,626 Pfizer shares in Q3 2026, an estimated $69.8K.
  • Pfizer made up 0.22% of Abel Hall LLC's portfolio in Q3 2026, its #56 holding.
  • Abel Hall LLC first reported a position in Pfizer in Q4 2023 and has held it in 12 quarters since.
  • 1,037 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Abel Hall LLC's 13F filing for Q3 2026, filed 19 Oct 2026.